Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Survival Curves01:18

Survival Curves

99
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
99
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

146
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
146
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

95
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
95
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

90
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

348
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
348

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Commensurate prior models with random effects for interval-censored data to accommodate historical controls.

Communications in statistics: Simulation and computation·2026
Same author

Lavandin cell extract enriched in rosmarinic acid attenuates inflammation via AMPK/Nrf2/HO-1 activation and IKK/IκB/NF-κB inhibition.

BMC plant biology·2026
Same author

Avoid All the Competitive Ones: Dynamics of Altruistic Behavior, Mediators, and Moderators in an Evacuation Drill.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Transplantation and cellular therapy·2026
Same author

A ratiometric fluorescent reporter of mitochondrial sodium.

Nature chemical biology·2026
Same author

STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer model.

Frontiers in immunology·2026

相关实验视频

Updated: Jun 3, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

211

为集群生存和竞争风险数据调整的曲线.

Manoj Khanal1, Soyoung Kim1, Kwang Woo Ahn1

  • 1Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Communications in statistics: Simulation and computation
|January 10, 2025
PubMed
概括

本研究介绍了调整的生存率和累积发病率曲线在右边审查数据中的方法. 新的R包adjSURVCI为改善临床试验分析提供了公正的估计.

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 临床试验 临床试验

背景情况:

  • 使用右翼审查数据的观测研究通常表现为集群 (例如,匹配对,研究中心).
  • 聚类数据可以导致治疗组之间的患者特征失衡.
  • 在这种情况下,未调整的生存率或累积发病率曲线 (例如,卡普兰-梅尔曲线) 可能会误导.

研究的目的:

  • 建议和实施用于估计调整后生存和累积发病概率的方法,以对右翼审查的数据进行聚类.
  • 在竞争风险结果中考虑协同变量独立和协同变量依赖的审查.
  • 为应用这些先进的统计方法提供一个用户友好的R包.

主要方法:

  • 开发新的统计方法,用于调整后的生存率和累积发病率估计,以集群的权利审查数据.
  • 结合灵活性来处理与不同类型的审查竞争的风险.
  • 这些方法在R包"adjSURVCI"中的实施.

主要成果:

  • 模拟研究表明,拟议的方法为调整后的生存率和累积发病概率提供了公正的估计.
  • 这些方法在模拟中达到约95%的覆盖率.
  • 开发的R包"adjSURVCI"成功地将这些方法应用于现实数据,例如干细胞移植结果.
关键词:
调整后的曲线.聚类的右翼审查数据.考克斯的比例危险模型.相对的分发危险模型的比例分发.在 R 套餐 adjSURVCI

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

相关实验视频

Last Updated: Jun 3, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

211
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

结论:

  • 拟议的方法有效地为聚类的权利审查数据提供调整的生存和累积发病概率.
  • "adjSURVCI" R包为研究人员处理复杂的生存数据提供了一个可靠的工具.
  • 准确的生存分析对于解释临床试验结果至关重要,特别是在存在集群和竞争风险的情况下.